Semaglutide Depression: What Regulators, Trials and Doctors Say About Mood and Suicidal Thoughts

Is there a link between semaglutide and depression? It's a fair question, and it comes up a lot. Forums and social media are full of people who say their mood dropped after starting treatment. Those stories matter, but they don't answer the question alone. This article looks at what the prescribing information, regulators and large reviews say about semaglutide depression concerns, and where the evidence is still unclear.

Why the question keeps coming up

Scroll through a diabetes group or a weight-loss forum and you'll find people describing sadness, irritability and anxiety during treatment. Many of these posts are detailed and heartfelt. Still, a personal story is one data point. A safety signal confirmed across many patients is something else entirely, and researchers work hard to keep the two apart.

Semaglutide is used by a very large number of people around the world. When a drug reaches that many users, even uncommon events will show up in everyday reports, whether or not the drug caused them. That's one reason our ongoing coverage of mood changes on OzemBlog focuses on what studies measure rather than on what a single post claims.

What the prescribing information says

The prescribing information, or label, is the official document that lists warnings, precautions and side effects. It gets updated as new data arrives, so the version you read today may differ from last year's. Check the current label on Drugs@FDA or the European product information, and look at the revision date at the top.

The boxed warning on Ozempic, the strongest warning type in US labeling, addresses the risk of thyroid C-cell tumors. It does not address mood or suicidal thoughts. Still, the label's precautions section is where new safety information gets added, which is why checking it regularly matters.

The most frequently reported side effects are gastrointestinal, including nausea, diarrhea, vomiting, constipation and stomach pain. That's the context doctors usually start with when someone feels unwell on the medicine, and it helps explain why a clinician will ask about digestion, eating and hydration as well as mood.

What regulators and large reviews have concluded

In 2024, the US Food and Drug Administration said it was evaluating reports of suicidal thoughts and actions in people taking GLP-1 medicines, including semaglutide. The agency drew on adverse event reports from its FAERS database. It did not conclude that these drugs cause suicidal thoughts, and it said it would keep monitoring the question.

The European Medicines Agency's safety committee, PRAC, also reviewed GLP-1 medicines and suicidal thoughts. Its review did not establish a causal link. Check the agency's website for the exact date and wording, since regulators sometimes update their conclusions as more data comes in.

Here's the key distinction. An association in spontaneous reports means some people who took a drug also reported an event. It doesn't prove the drug caused it. People on a medicine may have other risk factors, existing conditions or reasons to report symptoms more often. Proving cause takes controlled data that compares groups, and that's a much higher bar.

Depression, obesity and why the baseline matters

Obesity and depression are linked in both directions in the research literature. People with depression can face a higher risk of weight gain, and excess weight is associated with depression too. That relationship is complicated, and it doesn't show that one condition simply causes the other.

The World Health Organization describes depression as one of the leading causes of disability worldwide, affecting hundreds of millions of people. That means many people who start semaglutide already have depression, or they have a history of it. Some have eating disorders, or they take other medicines that affect mood, such as corticosteroids or certain sleep aids. A low mood during treatment may have started before the first dose.

The STEP trials of semaglutide 2.4 mg, the dose sold as Wegovy, tracked psychiatric events. If you want the details, read the published papers directly instead of relying on summaries, since the exact rates matter for interpreting the results.

Separating side effects from the underlying condition

When someone reports a mood change, a doctor usually reviews several things: earlier mood history, other medicines, sleep, appetite, alcohol use and how quickly weight is changing. Rapid weight loss, poor sleep and skipped meals can all affect mood, regardless of which medicine is involved.

Doctors also use screening tools. The PHQ-9 is a nine-question depression questionnaire, and a score of 10 or higher is the cutoff most often used to flag possible depression. For people with type 2 diabetes, scales such as the PAID or DDS questionnaires measure diabetes-related distress, which can look a lot like low mood. Using a standard tool keeps the conversation concrete.

Stopping the medicine on your own can be risky. It can affect blood sugar and weight, and it won't tell you what's causing the symptoms. Dose changes should be discussed with the team that prescribes the medicine. Bring up mood changes early so they can adjust treatment or check for other causes. If you want a structured way to prepare, the OzemBlog guide for organizing questions for your doctor walks through what to track and how to phrase your concerns.

Semaglutide does not affect everyone's mood in the same way. For some people, better weight and blood sugar control may ease stress and improve how they feel. For others, mood may dip. Your experience can fall anywhere on that range, which is why individual monitoring makes sense.

When to get help and what to bring to the appointment

Some signs need immediate contact with a doctor or emergency services. Watch for these three:

• Thoughts of death, self-harm or suicide
• Sudden withdrawal from family, friends or daily activities
• Confusion, agitation or sharp changes in behavior

In the US, call 911 in an emergency, or contact 988 for crisis support. In Brazil, the CVV can be reached at 188, free of charge and any time of day.

Bring a few things to your appointment: a simple diary of mood and sleep, your doses and dates, a full list of other medicines, and notes on mental health history in your family and in your own life. Then ask direct questions such as, 'Could this symptom come from the medicine or from another condition?' 'Is there an alternative if it happens?' and 'When should I come back?'

What we know, what to watch and what's still unclear

The solid evidence so far is this: the most common side effects in the label are gastrointestinal, and regulators who reviewed reports of suicidal thoughts have not established a causal link. Individual reports of mood change or suicidal thoughts still deserve prompt attention, whatever the cause. What remains unclear is how semaglutide may affect depression risk over long periods, and in which people.

Talk with your healthcare professional before making any decision about treatment, including stopping, switching or changing a dose. Other OzemBlog pieces on safety can give you more background, but they don't replace a conversation with the person who knows your health history.

FAQ

Can Ozempic cause suicidal thoughts?

Regulators have reviewed reports and have not concluded that semaglutide causes suicidal thoughts. Any thoughts of suicide still need urgent attention, so contact a doctor or a crisis line right away.

Is depression listed in the Ozempic prescribing information?

Check the current label on Drugs@FDA or the European product information, since the list of warnings and side effects changes over time. Read the revision date to confirm you're looking at the latest version.

How can I tell a medication side effect from depression?

Track your mood, sleep and appetite, and note when symptoms started relative to your doses. Then ask your clinician to screen you with a standard questionnaire such as the PHQ-9.

Should I stop semaglutide if I start feeling down?

Don't stop on your own. Stopping suddenly can affect blood sugar and weight, and mood changes need proper evaluation. Call your prescriber first so they can review your symptoms and options.

Sources

• FDA Drug Safety and Availability
• Drugs@FDA: FDA-Approved Drug Products
• European Medicines Agency
• WHO Depression Fact Sheet
• Novo Nordisk
• 988 Suicide and Crisis Lifeline
• Centro de Valorização da Vida (CVV)
• PHQ Screeners